Chronic mucus hypersecretion, exacerbations and natural history of COPD

Experimental Lung Research

Volumn 31, Issue SUPPL. 1, 2005, Pages 63-65

  Vestbo, J ^a  

^a North West Lung Centre ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MORTALITY; MUCUS SECRETION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION;

BRONCHITIS, CHRONIC; FORCED EXPIRATORY VOLUME; HUMANS; MUCUS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE;

EID: 25444463304     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Annesi I, Kauffmann F: Is respiratory mucus hypersecretion really an innocent disorder? Am Rev Respir Dis. 1986;134:688-93.
2. Ciba guest symposium. Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. Thorax. 1959;14:286-99.
3. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; 57:847-52.
4. Ebi-Kryston KL: Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study. J Clin Epidemiol. 1988;41:251-60.
5. Ebi-Kryston KL: Predicting 15 year chronic bronchitis mortality in the Whitehall Study. J Epidemiol Comm Health. 1989;43:168-72.
6. Fletcher CM, Peto R, Tinker C, Speizer FE: The Natural History of Chronic Bronchitis and Emphysema. Oxford: Oxford University Press; 1976.
7. Fletcher C, Peto R: The natural history of chronic airflow obstruction. Br Med J. 1977;1:1645-8.
8. Higgins MW, Keller JB, Becker M, Howatt W, Landis JR, Rotman H: et al. An index of risk for obstructive airways disease. Am Rev Respir Dis. 1982;125:144-51.
9. 1 decline in current smokers but not ex-smokers with mild chronic obstructive airways disease. Am J Resp Crit Care Med. 2001;164:358-64.
10. Kauffmann F, Drouet D, Lellouch J, Brille D: Twelve years spirometric changes among Paris area workers. Int J Epidemiol. 1979;8:201-12.
11. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P: Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax. 1990;45:579-85.
12. Lange P, Parner J, Prescott E, Vestbo J: Chronic bronchitis in an elderly population. Age and Ageing. 2003;32:636-42.
13. Medical research council's committee on the aetiology of chronic bronchitis. Standardized Questionnaires on Respiratory Symptoms. Br Med J. 1960;2:1665.
14. Medical research council. Instructions for the Use of the Questionnaire on Respiratory Symptoms. Devon: WJ. Holman Ltd; 1966.
15. Peto R, Speizer FE, Cochrane AL, Moore F, Fletcher CM Tinker CM et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis. 1983;128:491-500.
16. Prescott E, Lange P, Vestbo J: Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J. 1995;8:1333-8.
17. Pride NB, Burrows B: Development of impaired lung function: Natural history and risk factors. In: Calverley P, Pride NB, eds. Chronic Obstructive Pulmonary Disease. London: Chapman & Hall; 1995.
18. Sherman CB, Xu X, Speizer FE, Ferris Jr. BG, Weiss ST, Dockery DW: Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis. 1992;46:855-9.
19. Speizer FE, Fay ME, Dockery DW, Ferris BG Jr: Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis. 1989;140(suppl.):S49-55.
20. 1 decline and COPD morbidity. Am J Respir Crit Care Med. 1996;153:1530-5.
21. Vestbo J, Lange P: Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2002;166:329-32.
22. Vollmer WM, McCamant LE, Johnson LR, Buist AS: Respiratory symptoms, lung function, and mortality in a screening center cohort. Am J Epidemiol. 1989;129:1157-69.
23. Wiles FJ, Hnizdo E: Relevance of airflow obstruction and mucus hypersecretion to mortality. Respir Med. 1991;85:27-35.